Literature DB >> 15761763

Visual improvement following trans-Tenon's retrobulbar triamcinolone acetonide infusion for polypoidal choroidal vasculopathy.

Akiko Okubo1, Motoko Ito, Taro Kamisasanuki, Taiji Sakamoto.   

Abstract

PURPOSE: To report a case of polypoidal choroidal vasculopathy (PCV) that was successfully treated by sub-Tenon's infusion of triamcinolone acetonide (TA).
METHODS: A 56-year-old Japanese man had PCV in his left eye with vision of 20/32. Fluorescein angiography demonstrated a hyper-fluorescent spot, and indocyanine green angiography showed marked leakage of dye from the polypoidal vessel. Optical coherence tomography showed anterior protrusion of highly reflective layers and subretinal fluid.
RESULTS: The patient underwent trans-Tenon's retrobulbar infusion of 12 mg TA. Subsequently, the reddish-orange lesion decreased in size and elevation with complete resolution of the serous retinal detachment, and visual acuity improved to 20/20. Visual acuity remained good through a 15-month follow-up during which the patient was free of endophthalmitis and elevated intraocular pressure.
CONCLUSIONS: Trans-Tenon's retrobulbar TA infusion is potentially effective in treating PCV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761763     DOI: 10.1007/s00417-005-1125-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  Polypoidal choroidal vasculopathy and central serous chorioretinopathy.

Authors:  R M Ahuja; S M Downes; P E Stanga; A H Koh; J R Vingerling; A C Bird
Journal:  Ophthalmology       Date:  2001-06       Impact factor: 12.079

2.  A study of laser photocoagulation for polypoidal choroidal vasculopathy.

Authors:  Mitsuko Yuzawa; Ryuzaburo Mori; Miho Haruyama
Journal:  Jpn J Ophthalmol       Date:  2003 Jul-Aug       Impact factor: 2.447

3.  Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation.

Authors:  A A Okada; T Wakabayashi; E Kojima; Y Asano; T Hida
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

4.  Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; P Hugger; G Sauder; S Panda-Jonas; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

5.  Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.

Authors:  A Martidis; D G Miller; T A Ciulla; R P Danis; R S Moorthy
Journal:  J Ocul Pharmacol Ther       Date:  1999-10       Impact factor: 2.671

6.  Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells.

Authors:  Philip L Penfold; Li Wen; Michele C Madigan; Nicholas J C King; Jan M Provis
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

7.  Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

Authors:  Maddalena Quaranta; Martine Mauget-Faÿsse; Gabriel Coscas
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

8.  Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.

Authors:  Kazuaki Nishijima; Masayo Takahashi; Joh Akita; Hideto Katsuta; Mai Tanemura; Hiroko Aikawa; Michiko Mandai; Hitoshi Takagi; Junichi Kiryu; Yoshihito Honda
Journal:  Am J Ophthalmol       Date:  2004-04       Impact factor: 5.258

9.  Treatment of polypoidal choroidal vasculopathy with photodynamic therapy.

Authors:  Richard F Spaide; Irene Donsoff; Deborah L Lam; Lawrence A Yannuzzi; Lee M Jampol; Jason Slakter; John Sorenson; K Bailey Freund
Journal:  Retina       Date:  2002-10       Impact factor: 4.256

10.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

  10 in total
  3 in total

1.  Two-year outcome of photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide for polypoidal choroidal vasculopathy.

Authors:  Isao Nakata; Akitaka Tsujikawa; Kenji Yamashiro; Atsushi Otani; Sotaro Ooto; Yumiko Akagi-Kurashige; Naoko Ueda-Arakawa; Daisuke Iwama; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-25       Impact factor: 3.117

2.  Systemic steroid-pulse therapy in a patient with idiopathic choroidal detachment: a case report.

Authors:  Takashi Kanamoto; Michiya Takamatsu
Journal:  Case Rep Ophthalmol       Date:  2012-02-17

Review 3.  Polypoidal choroidal vasculopathy: an update on therapeutic approaches.

Authors:  Raymond L M Wong; Timothy Y Y Lai
Journal:  J Ophthalmic Vis Res       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.